ÂÜÀòÂÒÂ×

Michael Goldberg has a 40-year career in building companies at the intersection of biology, medicine, and computation primarily in oncology, immunology, and cardiology. His exposure to ultrasound dates back to the mid-1980s through an early investment in Acuson.